Tags

Type your tag names separated by a space and hit enter

Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands.
Emerg Infect Dis. 2020 11; 26(11):2761-2763.EI

Abstract

We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32726200

Citation

Petersen, Maria Skaalum, et al. "Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands." Emerging Infectious Diseases, vol. 26, no. 11, 2020, pp. 2761-2763.
Petersen MS, Strøm M, Christiansen DH, et al. Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands. Emerg Infect Dis. 2020;26(11):2761-2763.
Petersen, M. S., Strøm, M., Christiansen, D. H., Fjallsbak, J. P., Eliasen, E. H., Johansen, M., Veyhe, A. S., Kristiansen, M. F., Gaini, S., Møller, L. F., Steig, B., & Weihe, P. (2020). Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands. Emerging Infectious Diseases, 26(11), 2761-2763. https://doi.org/10.3201/eid2611.202736
Petersen MS, et al. Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands. Emerg Infect Dis. 2020;26(11):2761-2763. PubMed PMID: 32726200.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands. AU - Petersen,Maria Skaalum, AU - Strøm,Marin, AU - Christiansen,Debes Hammershaimb, AU - Fjallsbak,Jógvan Páll, AU - Eliasen,Eina Hansen, AU - Johansen,Malan, AU - Veyhe,Anna Sofía, AU - Kristiansen,Marnar Fríðheim, AU - Gaini,Shahin, AU - Møller,Lars Fodgaard, AU - Steig,Bjarni, AU - Weihe,Pál, Y1 - 2020/07/29/ PY - 2020/7/30/pubmed PY - 2020/11/5/medline PY - 2020/7/30/entrez KW - 2019 novel coronavirus disease KW - COVID-19 KW - Denmark KW - Faroe Islands KW - SARS-CoV-2 KW - antibodies KW - coronavirus disease KW - respiratory diseases KW - seroprevalence KW - severe acute respiratory syndrome coronavirus 2 KW - viruses KW - zoonoses SP - 2761 EP - 2763 JF - Emerging infectious diseases JO - Emerg Infect Dis VL - 26 IS - 11 N2 - We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response. SN - 1080-6059 UR - https://www.unboundmedicine.com/medline/citation/32726200/Seroprevalence_of_SARS_CoV_2_Specific_Antibodies_Faroe_Islands_ L2 - https://doi.org/10.3201/eid2611.202736 DB - PRIME DP - Unbound Medicine ER -